Objective: To establish size exclusion chromatography(SEC) and sodium dodecyl sulfate capillary electrophoresis(CE-SDS) for the determination of the molecular fractions in urokinase,and the methodological validation and sample determination results of the two methods were compared. Methods: SEC was performed on a TSKgel G2000SWXL column(7.8 mm×300 mm,5 μm) with 40.1 mol·L-1 sodium dihydrogen phosphate buffer (pH 3.0) mobile phase as the mobile phase,the flow rate was 0.5 mL·min-1,the column temperature was 35 ℃, the detection wavelength was 280 nm and the injection volume was 50 μL.CE-SDS was performed on a uncoated fused quartz capillary tube(50 μm×30.2 cm,effective length 20.2 cm),the separation voltage was 15 kV,the column temperature was 25 ℃,the detection wavelength was 214 nm,the injection end was positive electrode and the injection pressure was 5 kV for 20 s. Results: By comparing the results of the methodological validation and sample determination results of the two methods,it was proved that the results of the two methods were almost the same.The SEC method results showed the linear relationship of high molecular mass and low molecular mass urokinase was good when the concentration of urokinase was in the range of 0.05-5.1 mg·mL-1.The detection limit of high molecular mass and low molecular mass urokinase was 1.5 μg·mL-1 and 5.1 μg·mL-1,respectively,and the lower limit of quantification was 5.1 μg·mL-1 and 16.9 μg·mL-1,respectively.The relative content range of high molecular mass and low molecular mass urokinase was 87.0%-96.4% and 3.6%-13.0%,respectively.The CE-SDS method results showed the linear relationship of high molecular mass and low molecular mass urokinase was good when the concentration of urokinase was in the range of 0.1-5.2 mg·mL-1.The detection limit of high molecular mass and low molecular mass urokinase was 2.5 μg·mL-1 and 51.8 μg·mL-1,respectively,and the lower limit of quantification was 7.5 μg·mL-1 and 155.4 μg·mL-1 respectively.The relative content range of high molecular mass and low molecular mass urokinase was 87.0%-96.4% and 3.6%-13.0%,respectively. Conclusion: Both methods are suitable for the determination of molecular fractions in urokinase and complement for each other.
YAN Cui-xia, XU Ming-ming, CHENG Jing, SUN Zhen, ZHENG Lu-xia, CHEN Gang, SHAO Hong
. Establishment and comparative study of two methods for the determination of molecular fractions in urokinase[J]. Chinese Journal of Pharmaceutical Analysis, 2021
, 41(1)
: 104
-110
.
DOI: 10.16155/j.0254-1793.2021.01.12
[1] BANSAL V,ROYCHOUDHURY PK.Production and purification of urokinase:a comprehensive review[J].Protein Expr Purif,2006, 45(1):1
[2] FLETCHER AP,ALKJAERSIG N,LEWIS M,et al.A pilot study of urokinase therapy in cerebral infarction[J].Stroke,1976,7(2):135
[3] 孙天霄,王红梅,徐长法.高分子量和低分子量尿激酶的分离纯化及动力学性质研究[J].生物化学杂志,1997,13(3):344
SUN TX,WANG HM,XU CF.Study on the separation and purification of high and low molecular weight urokinase and its kinetic properties[J].Chin Biochem J,1997,13(3):344
[4] WHITE WF, BARLOW GH,MOZEN MM.The isolation and characterization of plasminogen activators(urokinase) from human urine[J].Biochemistry,1966,5(7):2160
[5] SOBERANO ME,ONG EB,JOHNSON AJ,et al.Purification and characterization of two forms of urokinase[J].Biochim Biophys Acta,1976,445(3):763
[6] 司师麟,汪继东,李皓,等.高比活大分子尿激酶的纯化[J].河北省科学院学报,1991,4(8):41
SI SL,WANG JD,LI H,et al.Purification of high specific activity macromolecule urokinase[J].J Hebei Acad Sci,1991,4(8):41
[7] 中华人民共和国药典2015 年版.二部[S].2015:532
ChP 2015.Vol ⅡhP 2015.Vol Ⅱ[S].2015:532
[8] BP 2019.Vol ⅡP 2019.Vol Ⅱ[S].2019:1219
[9] EP10.0.Vol Ⅲ[S].2019:4151
[10] JP ⅩⅦ[S].2016:1747
[11] 雷大卫,徐德明,单拓生.一种快速测定尿激酶比活力和分子量的方法[J].贵阳医学学报,1991,16(1):39
LEI DW,XU DM,SHAN TS.A method of quickly determinating the specific activity and molcular weight of urokinase-study on quality of semifinished urokinase produced in Guiyang area[J].J Guiyang Med Coll,1991,16(1):39
[12] 祝一锋,蔡志亮,赵忠睦,等.高分子量尿激酶比率的测定[J].中国抗生素杂志,1998,23(5):388
ZHU YF,CAI ZL,ZHAO ZM,et al.Quantitative determination of the HMW-urokinase's ratio[J].Chin J Antibiot,1998,23(5): 388
[13] 王建锋,乔玉玲,秦海燕,等.应用CE-SD 测定抗CD52 人源化单克隆抗体参比品单体纯度及非糖化重链比例[J].现代生物医学进展,2018,18(15):2836
WANG JF,QIAO YL,QIN HY,et al.CE-SDS were applied to determine monomer purity and proportion of non-glycosylated heavy chain in reference products of anti-CD52 humanized monoclonal antibody[J].Prog Mod Biomed,2018,18(15):2836
[14] 刘振东,高铁,徐玲丽,等.十二烷基硫酸钠毛细管电泳法分析非还原单克隆抗体药物纯度的前处理条件优化[J].色谱,2019,37(6):666
LIU ZD,GAO T,XU LL,et al.Optimization of sample preparation condition for sodium dodecyl sulfate capillary electrophoresis of nonreduced monoclonal antibodies[J].Chin J Chromatogr,2019,37(6):660
[15] 中华人民共和国药典2015 年版.四部[S].2015:237
ChP 2015.Vol ⅣhP 2015.Vol Ⅳ[S].2015:237